Home›Search›Frontiers in Oncology

Frontiers in Oncology

Frontiers Media S.A. · Switzerland · Est. 1906

eISSN2234-943X
SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
◆ WoS flagship (SCIE/SSCI/AHCI)78
✓ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates — we never estimate
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
1.02
H-Indexi
204
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
0.86
Total Worksi
35,828
Total Citationsi
609,944
2yr Mean Citednessi
2.24
Open Impact Factor alternative

Aims & Scope

Frontiers in Oncology is a high-impact open-access journal that publishes rigorous research on all aspects of oncology. We aim to provide a platform for the rapid dissemination of novel findings and clinical advancements in cancer research and treatment. Our scope includes, but is not limited to, the following areas: Cancer Biology, Cancer Imaging, Cancer Immunity, Cancer Prevention, Cancer Therapy, Clinical Oncology, Experimental Oncology, Medical Oncology, Pediatric Oncology, Radiation Oncology, Surgical Oncology, and Translational Oncology.

General Information

Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published1906
StatusActive (last: 2026)
Total Publications35,828
Publisher OrgFrontiers Media
OA Since2010
Visit Journal Website

Submission Info

APC CostCHF 3,150
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY
OA Rate—

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
CLOCKSSPMC

Think.Check.Submit Compliance

11/12 · 92%
✅
Do you know the journal / publisher?
Frontiers Media S.A.
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
2234-943X
✅
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
✅
Peer review process documented?
Anonymous peer review
❌
Follows ethical publishing standards (COPE)?
N/A
✅
APC fees clearly disclosed?
CHF 3,150
✅
Not on predatory/blacklists?
✓ Clean
✅
Long-term digital preservation?
CLOCKSS, PMC
✅
Plagiarism detection in place?
Yes
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ2
OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisRadiomics and Machine Learning in Medical ImagingCancer-related molecular mechanisms researchGlioma Diagnosis and TreatmentLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentRNA modifications and cancerHepatocellular Carcinoma Treatment and PrognosisLung Cancer Research Studies

Frequently asked questions about Frontiers in Oncology

Is Frontiers in Oncology a predatory journal?

PubScope has no integrity flags on record for Frontiers in Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Frontiers in Oncology?

Frontiers in Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.24.

Is Frontiers in Oncology indexed in Scopus and Web of Science?

Frontiers in Oncology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Frontiers in Oncology?

Frontiers in Oncology is a high-impact open-access journal that publishes rigorous research on all aspects of oncology. We aim to provide a platform for the rapid dissemination of novel findings and clinical advancements in cancer research and treatment. Our scope includes, but is not limited to, the following areas: Cancer Biology, Cancer Imaging, Cancer Immunity, Cancer Prevention, Cancer Therapy, Clinical Oncology, Experimental Oncology, Medical Oncology, Pediatric Oncology, Radiation Oncology, Surgical Oncology, and Translational Oncology.

How much does it cost to publish in Frontiers in Oncology?

Frontiers in Oncology charges an article processing charge (APC) of about CHF 3,150 for open-access publication.

You May Also Like

See all →
Frontiers in Oncology
Frontiers Media S.A.
SJR Q2SCIEOA
Cancers
Multidisciplinary Digital Publishing Institute (MDPI)
SJR Q1SCIE
Oncologie
Walter de Gruyter GmbH
SJR Q3SCIEOA
Cancer Management and Research
Dove Medical Press Ltd
SJR Q2SCIEOA
Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref